Christelle D. L.
- Country
- France
- Department
- 2101 Rheumatology
Research Overview
- A two part, randomized, participant and investigator-blinded, 2-arm, parallel-design, placebo-controlled study to evaluate the safety, tolerability and preliminary efficacy of NGI226 microparticles on tendon regeneration in patients with Achilles tendinopathy
- A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of Secukinumab 300 mg Subcutaneous in Adults with Moderate to Severe Rotator Cuff Tendinopathy
Data & Insights
Has run more than one trial at 1 of 28 partner sites.
Specializations
Tendinopathy Research
This investigator specializes in advancing treatments for various forms of tendinopathy, with particular focus on both upper and lower extremity conditions.
- Rotator cuff tendinopathy management
- Achilles tendinopathy interventions
- Novel therapeutic approaches
The investigator explores innovative treatment modalities including biological agents and microparticle-based therapies for tendon disorders.
Musculoskeletal Medicine
Research activities center on addressing moderate to severe manifestations of musculoskeletal conditions affecting major tendons.
- Upper extremity disorders
- Lower extremity conditions
- Injectable therapeutics
The investigator evaluates both systemic and local treatment approaches for musculoskeletal pathologies.
Therapeutic Innovation
Focus areas include assessment of novel therapeutic agents including biological treatments and specialized delivery systems.
- Peritendon injection techniques
- Microparticle therapeutics
- Subcutaneous treatment methods
The investigator studies both established and emerging treatment modalities for tendon disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.